BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23697940)

  • 1. Could lncRNAs contribute to β-cell identity and its loss in Type 2 diabetes?
    Pullen TJ; Rutter GA
    Biochem Soc Trans; 2013 Jun; 41(3):797-801. PubMed ID: 23697940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long noncoding RNA
    Zhou AX; Mondal T; Tabish AM; Abadpour S; Ericson E; Smith DM; Knöll R; Scholz H; Kanduri C; Tyrberg B; Althage M
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E846-E857. PubMed ID: 33682459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of islet-enriched long non-coding RNAs contributing to β-cell failure in type 2 diabetes.
    Motterle A; Gattesco S; Peyot ML; Esguerra JLS; Gomez-Ruiz A; Laybutt DR; Gilon P; Burdet F; Ibberson M; Eliasson L; Prentki M; Regazzi R
    Mol Metab; 2017 Nov; 6(11):1407-1418. PubMed ID: 29107288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of long non-coding RNAs in the regulation of pancreatic beta cell identity.
    Wilson ME; Pullen TJ
    Biochem Soc Trans; 2021 Nov; 49(5):2153-2161. PubMed ID: 34581756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications and long noncoding RNAs influence pancreas development and function.
    Arnes L; Sussel L
    Trends Genet; 2015 Jun; 31(6):290-9. PubMed ID: 25812926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of β Cell Identity and Dysfunction.
    Sun X; Wang L; Obayomi SMB; Wei Z
    Front Endocrinol (Lausanne); 2021; 12():725131. PubMed ID: 34630329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs as novel biomarkers for Type 2 diabetes.
    Zhu H; Bian X; Gong J; Yu P; Lu H
    Biomark Med; 2020 Oct; 14(15):1501-1511. PubMed ID: 33155821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic control of β-cell function and failure.
    Bernstein D; Golson ML; Kaestner KH
    Diabetes Res Clin Pract; 2017 Jan; 123():24-36. PubMed ID: 27918975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LEGLTBC Functions as a ceRNA to Antagonize the Effects of miR-34a on the Downregulation of SIRT1 in Glucolipotoxicity-Induced INS-1 Beta Cell Oxidative Stress and Apoptosis.
    Kong X; Liu CX; Wang GD; Yang H; Yao XM; Hua Q; Li XY; Zhang HM; Ma MZ; Su Q; Lv K
    Oxid Med Cell Longev; 2019; 2019():4010764. PubMed ID: 31737170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes.
    Morán I; Akerman I; van de Bunt M; Xie R; Benazra M; Nammo T; Arnes L; Nakić N; García-Hurtado J; Rodríguez-Seguí S; Pasquali L; Sauty-Colace C; Beucher A; Scharfmann R; van Arensbergen J; Johnson PR; Berry A; Lee C; Harkins T; Gmyr V; Pattou F; Kerr-Conte J; Piemonti L; Berney T; Hanley N; Gloyn AL; Sussel L; Langman L; Brayman KL; Sander M; McCarthy MI; Ravassard P; Ferrer J
    Cell Metab; 2012 Oct; 16(4):435-48. PubMed ID: 23040067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs.
    Goyal N; Kesharwani D; Datta M
    Cell Mol Life Sci; 2018 May; 75(10):1827-1837. PubMed ID: 29387902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNAs as Key Modulators of Pancreatic β-Cell Mass and Function.
    López-Noriega L; Rutter GA
    Front Endocrinol (Lausanne); 2020; 11():610213. PubMed ID: 33628198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating LncRNAs Analysis in Patients with Type 2 Diabetes Reveals Novel Genes Influencing Glucose Metabolism and Islet β-Cell Function.
    Ruan Y; Lin N; Ma Q; Chen R; Zhang Z; Wen W; Chen H; Sun J
    Cell Physiol Biochem; 2018; 46(1):335-350. PubMed ID: 29590649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of long non-coding RNAs in the determination of β-cell identity.
    Motterle A; Sanchez-Parra C; Regazzi R
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():41-50. PubMed ID: 27615130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifiers of islet function and mass.
    De Jesus DF; Kulkarni RN
    Trends Endocrinol Metab; 2014 Dec; 25(12):628-36. PubMed ID: 25246382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could microRNAs contribute to the maintenance of β cell identity?
    Kaspi H; Pasvolsky R; Hornstein E
    Trends Endocrinol Metab; 2014 Jun; 25(6):285-92. PubMed ID: 24656914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
    Moin ASM; Butler AE
    Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA-regulated pathways in pancreatic β cells: Their role in diabetes.
    González-Moro I; Santin I
    Int Rev Cell Mol Biol; 2021; 359():325-355. PubMed ID: 33832652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.